ENBREL
Google image searchProduct monograph
Active ingredient
etanercept, 50 MG/ML
DIN: 02274728
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Schedule: Prescription / Schedule D
Company: IMMUNEX CORPORATION
Date: 21-DEC-2005
ATC:
- L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
- L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
- L04AB — Tumor necrosis factor alpha (TNF-alpha) inhibitors (ATC, ATC/DDD)
- L04AB01 — ETANERCEPT (ATC/DDD)
Reference brand drug: Enbrel
